| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/25/1998 | CN1199774A Chinese medicinal stone wine and its making process |
| 11/25/1998 | CN1199641A Chinese medicine preparation for preventing and curing cerebral thrombus |
| 11/25/1998 | CN1199639A Chinese medicine preparation for curing osteonecrosis |
| 11/25/1998 | CN1199634A Medicine for hernia and its preparation process and medicated deltoid belt |
| 11/25/1998 | CN1199633A Chinese medicine composite for curing chronic upper jaw sinuitis |
| 11/25/1998 | CN1199620A Chinese patent drug for intractable headache |
| 11/25/1998 | CN1199619A Chinese patent drug for pharyngitis |
| 11/25/1998 | CN1199618A Chinese patent drug for women's diseases |
| 11/25/1998 | CN1199617A Chinese patent drug for eye disease |
| 11/25/1998 | CN1199616A Deer embryo health article and its preparation |
| 11/25/1998 | CN1199615A Preparation of multiple mineral element health care tablet |
| 11/24/1998 | US5840857 Purification of post-menopausal urinary concentrate by immunochromatography and reverse phase high pressure liquid chromatography; biologically active product is free from lutenizing hormone and other proteins; fertility agents |
| 11/24/1998 | US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 11/24/1998 | US5840750 Discodermolide compounds |
| 11/24/1998 | US5840713 Therapy for tissue membrane insufficiency |
| 11/24/1998 | US5840701 Antiischemic agents and macomolecules |
| 11/24/1998 | US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 11/24/1998 | US5840585 Purifying antibody that specifically binds to native rh antigen by contacting samply with immobilized antigenically-active rh antigen then eluting |
| 11/24/1998 | US5840580 Population of human cells that lacks mature progenitor cells of the erythroid, lymphoid, and myeloid lineages and is enriched for hematopoietic stem cells |
| 11/24/1998 | US5840496 Method for diagnosing endometrial cancer |
| 11/24/1998 | US5840342 Shark liver extract for stimulating the immune system |
| 11/24/1998 | US5840318 Growing bacteria, exposing to biological, chemical or physical stress to cause bacteria to release stress release product, separating, filtering, administering to animal |
| 11/24/1998 | US5840309 Composition comprising two glycoproteins, ginseng extract and horsetail extract |
| 11/24/1998 | US5840304 Amino acid sequences and codes for t-cells |
| 11/24/1998 | US5840302 Treatment of bacterially-induced inflammatory diseases |
| 11/23/1998 | CA2206047A1 Immunomodulating compositions for the treatment of viral disorders |
| 11/19/1998 | WO1998051808A1 Methods for producing retroviral vectors with an altered tropism |
| 11/19/1998 | WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 11/19/1998 | WO1998051660A1 Methods and compositions for the selective modification of nucleic acids |
| 11/19/1998 | WO1998051353A2 Artificial bodily fluid |
| 11/19/1998 | WO1998051340A1 Fas ligand expressing antigen presenting cells for tolerance induction |
| 11/19/1998 | WO1998051318A1 Pharmaceutical composition and diagnostic kit directed to a heterologeneous pathogenic organism in a host |
| 11/19/1998 | WO1998051317A1 Osteoarthritis cartilage regeneration using human mesenchymal stem cells |
| 11/19/1998 | WO1998051316A1 Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity |
| 11/19/1998 | WO1998051260A2 Use of d-arginine and/or l-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls |
| 11/19/1998 | WO1998051147A1 Prolonged cold storage of red blood cells by oxygen removal and additive usage |
| 11/19/1998 | WO1998040086A3 Essential oil composition |
| 11/19/1998 | WO1998035014A3 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 11/19/1998 | CA2289953A1 Methods for producing retroviral vectors with an altered tropism |
| 11/19/1998 | CA2289619A1 Methods and compositions for the selective modification of nucleic acids |
| 11/19/1998 | CA2289610A1 Pharmaceutical composition and diagnostic kit directed to a heterologeneous pathogenic organism in a host |
| 11/19/1998 | CA2288690A1 Osteoarthritis cartilage regeneration using human mesenchymal stem cells |
| 11/19/1998 | CA2286875A1 Chemical compounds |
| 11/18/1998 | EP0878547A1 Methods for producing retroviruses with an altered tropism |
| 11/18/1998 | EP0878546A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin |
| 11/18/1998 | EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 11/18/1998 | EP0877797A1 Improved immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
| 11/18/1998 | EP0877795A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 11/18/1998 | EP0877760A1 Mhc complexes and uses thereof |
| 11/18/1998 | EP0877757A1 Method for evaluating and affecting male fertility |
| 11/18/1998 | EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
| 11/18/1998 | EP0877620A1 Peptides for altering osteoblast adhesion |
| 11/18/1998 | EP0877555A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 11/18/1998 | EP0696312B1 Process for obtaining high-purity egg oil and use thereof |
| 11/18/1998 | EP0690990B1 Parvovirus receptors and methods of use |
| 11/18/1998 | EP0551501B1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 11/18/1998 | CN1199093A Health wine with active components of scorpion and ant and its preparation process |
| 11/18/1998 | CN1199050A Method for preparation of mother-of-pearl glycosaminoglycan |
| 11/18/1998 | CN1198936A Chinese and Western medicine capsule for curing psoriasis and leucodermia in sleep |
| 11/18/1998 | CN1198935A Acne eliminating pill |
| 11/18/1998 | CN1198934A Medicated wine for curing rheumarthritis and rheumatoid arthritis and its preparation process |
| 11/18/1998 | CN1198931A Kidney-reinforcing Yang strengthening powder |
| 11/18/1998 | CN1040724C Method for preparing consciousness- and speech-restoring pill |
| 11/18/1998 | CN1040723C Method for preparation of numbness and pain relieving massage emulsion |
| 11/17/1998 | US5837842 Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use |
| 11/17/1998 | US5837812 Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides |
| 11/17/1998 | US5837543 Human embryo co-culture system and uses thereof |
| 11/17/1998 | US5837539 Monoclonal antibodies for human mesenchymal stem cells |
| 11/17/1998 | US5837532 Herpes simplex cirus type 1 mutant |
| 11/17/1998 | US5837531 Recombinant adenoviruses for gene therapy in cancers |
| 11/17/1998 | US5837519 Dry-heat viral inactivation under controlled moisture conditions |
| 11/17/1998 | US5837510 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 11/17/1998 | US5837498 Corpuscles of stannius protein, stanniocalcin |
| 11/17/1998 | US5837472 Nucleotide sequences coding for a protein with urease activity |
| 11/17/1998 | US5837451 Identifying composition which affect kinase activity |
| 11/17/1998 | US5837441 Immunoassay for detecting human antibodies to the hards virus, the etiologic aganet of hantavirus-associated respiratory distress syndrome |
| 11/17/1998 | US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 11/17/1998 | US5837238 Using lactobacillus reuteri for treatment of diarrhea caused by rotavirus |
| 11/17/1998 | US5837236 Antigens and cells for insulin secretion, stimulants for immune response against cells in xenogenic subjects |
| 11/17/1998 | US5837234 Cell cores and encapsulation |
| 11/17/1998 | US5837233 Method for treating tumors |
| 11/12/1998 | WO1998050542A1 Uncoupling protein homologue: ucp 3 |
| 11/12/1998 | WO1998050527A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 11/12/1998 | WO1998050525A1 Embryonic and adult cns stem cells |
| 11/12/1998 | WO1998050079A2 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes |
| 11/12/1998 | WO1998050054A1 Plant extracts for the treatment of increase bone resorption |
| 11/12/1998 | WO1998050053A1 Gene transfer with adenoviruses having modified fiber proteins |
| 11/12/1998 | WO1998050052A1 Novel use of phospholipids of animal origin in therapy and/or dietetics |
| 11/12/1998 | WO1998050048A1 Aplidine as an l-type calcium channel enhancer |
| 11/12/1998 | WO1998050046A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
| 11/12/1998 | WO1998049906A1 Peri-operative drink |
| 11/12/1998 | WO1998032457A3 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 11/12/1998 | CA2289742A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 11/12/1998 | CA2289215A1 Gene transfer with adenoviruses having modified fiber proteins |
| 11/12/1998 | CA2289124A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
| 11/12/1998 | CA2288901A1 Uncoupling protein homologue: ucp 3 |
| 11/12/1998 | CA2288639A1 Aplidine as an l-type calcium channel enhancer |
| 11/12/1998 | CA2259484A1 Embryonic and adult cns stem cells |
| 11/11/1998 | EP0877032A1 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 11/11/1998 | EP0876813A1 Composition containing a microorganism culture medium |